Decreased local failure in all patients treated with PBT, statistically significant
in the high-risk group (Gleason 8-10)
.
Increased rectal bleeding (primarily grade 1) in the high-dose group.
No difference in overall survival.
MGH Phase III randomized trial
Shipley et al, IJROBP, 32: 3-12, 1995